Nikolaou M, Pavlopoulou A, Georgakilas A, Kyrodimos E
Clin Exp Metastasis. 2018; 35(4):309-318.
PMID: 29799080
DOI: 10.1007/s10585-018-9903-0.
Kim D, Lee E, Oh K, Gao Z, Bae Y
Small. 2008; 4(11):2043-50.
PMID: 18949788
PMC: 2582593.
DOI: 10.1002/smll.200701275.
Mukai M, Che X, Furukawa T, Sumizawa T, Aoki S, Ren X
Cancer Sci. 2003; 94(6):557-63.
PMID: 12824882
PMC: 11160154.
DOI: 10.1111/j.1349-7006.2003.tb01482.x.
Van Niekerk E, OSullivan J, Joone G, Van Rensburg C
Invest New Drugs. 2001; 19(3):211-7.
PMID: 11561677
DOI: 10.1023/a:1010691714635.
Lehnert M, Mross K, Schueller J, Thuerlimann B, Kroeger N, Kupper H
Br J Cancer. 1998; 77(7):1155-63.
PMID: 9569055
PMC: 2150143.
DOI: 10.1038/bjc.1998.192.
Full blockade of intestinal P-glycoprotein and extensive inhibition of blood-brain barrier P-glycoprotein by oral treatment of mice with PSC833.
Mayer U, Wagenaar E, Dorobek B, Beijnen J, Borst P, Schinkel A
J Clin Invest. 1997; 100(10):2430-6.
PMID: 9366556
PMC: 508442.
DOI: 10.1172/JCI119784.
Classical multidrug resistance in acute myeloid leukaemia.
Paietta E
Med Oncol. 1997; 14(1):53-60.
PMID: 9232613
DOI: 10.1007/BF02990947.
Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins.
Schinkel A, Mayer U, Wagenaar E, Mol C, van Deemter L, Smit J
Proc Natl Acad Sci U S A. 1997; 94(8):4028-33.
PMID: 9108099
PMC: 20562.
DOI: 10.1073/pnas.94.8.4028.
Molecular biology of leukemia for the clinician.
Paietta E
Med Oncol. 1995; 12(3):157-66.
PMID: 8852398
DOI: 10.1007/BF01571193.
MDR1 P-glycoprotein is expressed by endothelial cells of newly formed capillaries in human gliomas but is not expressed in the neovasculature of other primary tumors.
Toth K, Vaughan M, Peress N, Slocum H, Rustum Y
Am J Pathol. 1996; 149(3):853-8.
PMID: 8780389
PMC: 1865160.
Primary breast cancer imaging with technetium-99m sestamibi and its relation with P-glycoprotein overexpression.
Moretti J, Azaloux H, Boisseron D, Kouyoumdjian J, Vilcoq J
Eur J Nucl Med. 1996; 23(8):980-6.
PMID: 8753690
DOI: 10.1007/BF01084375.
Dexverapamil to modulate vinblastine resistance in metastatic renal cell carcinoma.
Mickisch G, Noordzij M, vd Gaast A, Gebreamlack P, Kohrmann K, Kupper H
J Cancer Res Clin Oncol. 1995; 121 Suppl 3:R11-6.
PMID: 8698736
DOI: 10.1007/BF02351065.
P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs.
Schinkel A, Wagenaar E, Mol C, van Deemter L
J Clin Invest. 1996; 97(11):2517-24.
PMID: 8647944
PMC: 507337.
DOI: 10.1172/JCI118699.
Distribution and activity of doxorubicin combined with SDZ PSC 833 in mice with P388 and P388/DOX leukaemia.
Colombo T, Gonzalez Paz O, DIncalci M
Br J Cancer. 1996; 73(7):866-71.
PMID: 8611397
PMC: 2074272.
DOI: 10.1038/bjc.1996.154.
Modulation of multidrug resistance by SDZ PSC 833 in leukemic and solid-tumor-bearing mouse models.
Watanabe T, Naito M, Itoh Y, Cohen D, Tsuruo T
Jpn J Cancer Res. 1996; 87(2):184-93.
PMID: 8609068
PMC: 5921055.
DOI: 10.1111/j.1349-7006.1996.tb03157.x.
Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport.
Muller M, Meijer C, Zaman G, Borst P, Scheper R, Mulder N
Proc Natl Acad Sci U S A. 1994; 91(26):13033-7.
PMID: 7809167
PMC: 45575.
DOI: 10.1073/pnas.91.26.13033.
Adjuvant chemotherapy improves survival after liver transplantation for hepatocellular carcinoma.
Olthoff K, Rosove M, Shackleton C, Imagawa D, Farmer D, Northcross P
Ann Surg. 1995; 221(6):734-41; discussion 731-43.
PMID: 7794077
PMC: 1234704.
DOI: 10.1097/00000658-199506000-00012.
Multidrug resistance in human cancer.
Lehnert M
J Neurooncol. 1994; 22(3):239-43.
PMID: 7760101
DOI: 10.1007/BF01052927.
The biology of the P-glycoproteins.
Arias I
J Membr Biol. 1995; 143(2):89-102.
PMID: 7731035
DOI: 10.1007/BF00234655.
Changes in doxorubicin distribution and toxicity in mice pretreated with the cyclosporin analogue SDZ PSC 833.
Gonzalez O, Colombo T, De Fusco M, Imperatori L, Zucchetti M, DIncalci M
Cancer Chemother Pharmacol. 1995; 36(4):335-40.
PMID: 7628053
DOI: 10.1007/BF00689051.
